Strides Pharma Science demerger effective from June 1, 2026
Strides Pharma Science Limited announced that the Scheme of Demerger involving Arco Lab Private Limited and Pivot Path Private Limited became effective from June 1, 2026. The transfer of the identified business follows the NCLT approval and the filing of the certified order with the Registrar of Companies.
*this image is generated using AI for illustrative purposes only.
Strides Pharma Science Limited has announced that the Scheme of Demerger involving Arco Lab Private Limited and Pivot Path Private Limited became effective from June 1, 2026. The demerger involves the transfer of the identified business of Arco Lab to Pivot Path. This development follows the approval granted by the Hon’ble National Company Law Tribunal (NCLT), Bengaluru Bench.
The company received the certified copy of the NCLT Order approving the Scheme of Demerger on May 25, 2026. Subsequently, the participating entities, Arco Lab and Pivot Path, filed the certified true copy of the order with the Registrar of Companies. This filing finalized the procedural requirements, rendering the scheme effective from the stipulated date.
Key Details of the Demerger
The following table summarizes the critical dates and entities involved in the Scheme of Demerger:
| Event | Date | Entity/Authority |
|---|---|---|
| NCLT Approval Reference | May 20, 2026 | National Company Law Tribunal, Bengaluru Bench |
| Receipt of Certified NCLT Order | May 25, 2026 | Strides Pharma Science Limited |
| Effective Date of Demerger | June 1, 2026 | Arco Lab Private Limited, Pivot Path Private Limited |
The Scheme of Demerger was approved by the NCLT, Bengaluru Bench, facilitating the transfer of the identified business from Arco Lab to Pivot Path. The intimation regarding the effective date was submitted to BSE Limited and The National Stock Exchange of India Limited under Regulation 30 of the SEBI Listing Regulations. Manjula Ramamurthy, Company Secretary of Strides Pharma Science Limited, signed the regulatory filing.
Historical Stock Returns for Strides Pharma Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.75% | -9.52% | +3.68% | +17.84% | +35.65% | +40.85% |
How will the demerger impact Strides Pharma's financial structure and operational efficiency?
What strategic benefits does Pivot Path expect to gain from acquiring Arco Lab's business?
How will the demerger affect the stock performance of Strides Pharma in the near term?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
